Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Buckner

Showing results (411-420 of 417) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 417 results.
Blood|May 15, 1997
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulinR Storb, W Leisenring, C Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?R Storb, W Leisenring, C Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 1996
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recoveryK M Sullivan, J Storek, K J Kopecky, et al.
Bone Marrow Transplantation|June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.
Blood|January 1, 1996
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factorsJ E Anderson, F R Appelbaum, G Schoch, et al.
Bone Marrow Transplantation|July 1, 1996
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cellsM W Brunvand, W I Bensinger, E Soll, et al.
Blood|April 15, 1997
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantationJ T Slattery, R A Clift, C D Buckner, et al.
Pageof 42

Showing results (411-420 of 417) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 417 results.
Blood|May 15, 1997
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulinR Storb, W Leisenring, C Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?R Storb, W Leisenring, C Anasetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 1996
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recoveryK M Sullivan, J Storek, K J Kopecky, et al.
Bone Marrow Transplantation|June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.
Blood|January 1, 1996
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factorsJ E Anderson, F R Appelbaum, G Schoch, et al.
Bone Marrow Transplantation|July 1, 1996
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cellsM W Brunvand, W I Bensinger, E Soll, et al.
Blood|April 15, 1997
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantationJ T Slattery, R A Clift, C D Buckner, et al.
Pageof 42